Literature DB >> 21403122

Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact.

Mark J Pletcher1, Michael Pignone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21403122      PMCID： PMC3138723          DOI： 10.1161/CIRCULATIONAHA.110.943860

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  59 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 2.  Diagnostic tests 4: likelihood ratios.

Authors:  Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2004-07-17

Review 3.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker.

Authors:  Margaret Sullivan Pepe; Holly Janes; Gary Longton; Wendy Leisenring; Polly Newcomb
Journal:  Am J Epidemiol       Date:  2004-05-01       Impact factor: 4.897

4.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

5.  Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach.

Authors:  P Doubilet; C B Begg; M C Weinstein; P Braun; B J McNeil
Journal:  Med Decis Making       Date:  1985       Impact factor: 2.583

6.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

7.  Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial.

Authors:  Patrick G O'Malley; Irwin M Feuerstein; Allen J Taylor
Journal:  JAMA       Date:  2003-05-07       Impact factor: 56.272

8.  Prognostic value of myeloperoxidase in patients with chest pain.

Authors:  Marie-Luise Brennan; Marc S Penn; Frederick Van Lente; Vijay Nambi; Mehdi H Shishehbor; Ronnier J Aviles; Marlene Goormastic; Michael L Pepoy; Ellen S McErlean; Eric J Topol; Steven E Nissen; Stanley L Hazen
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

9.  The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.

Authors:  H A Ashton; M J Buxton; N E Day; L G Kim; T M Marteau; R A P Scott; S G Thompson; N M Walker
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

10.  Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Authors:  Christian Mueller; André Scholer; Kirsten Laule-Kilian; Benedict Martina; Christian Schindler; Peter Buser; Matthias Pfisterer; André P Perruchoud
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245
View more
  34 in total

Review 1.  An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.

Authors:  Anil N Makam; Oanh K Nguyen
Journal:  Circulation       Date:  2017-01-10       Impact factor: 29.690

Review 2.  New measures of mental state and behavior based on data collected from sensors, smartphones, and the Internet.

Authors:  Tasha Glenn; Scott Monteith
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

Review 3.  Microvesicles: potential markers and mediators of endothelial dysfunction.

Authors:  Ming-Lin Liu; Kevin Jon Williams
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

4.  Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.

Authors:  Mark J Pletcher; Michael Pignone; Stephanie Earnshaw; Cheryl McDade; Kathryn A Phillips; Reto Auer; Lydia Zablotska; Philip Greenland
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-03-11

Review 5.  Genetics of coronary artery disease.

Authors:  Wolfgang Lieb; Ramachandran S Vasan
Journal:  Circulation       Date:  2013-09-03       Impact factor: 29.690

Review 6.  Role of C-reactive protein when prescribing a statin.

Authors:  Scott Kinlay
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

7.  Interpreting Hemoglobin A1C in Combination With Conventional Risk Factors for Prediction of Cardiovascular Risk.

Authors:  Jamie A Jarmul; Michael Pignone; Mark J Pletcher
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-09

Review 8.  Mechanism and biomarkers in aortitis--a review.

Authors:  Benjamin Benhuri; Ammar ELJack; Bashar Kahaleh; Ritu Chakravarti
Journal:  J Mol Med (Berl)       Date:  2019-10-30       Impact factor: 4.599

Review 9.  Risk assessment in the prevention of cardiovascular disease in low-resource settings.

Authors:  Sandra N Ofori; Osaretin J Odia
Journal:  Indian Heart J       Date:  2015-08-29

Review 10.  Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?: Clinical risk scores are sufficient to define primary prevention treatment strategies among asymptomatic patients.

Authors:  Charlotte Andersson; Ramachandran S Vasan
Journal:  Circ Cardiovasc Imaging       Date:  2014-03       Impact factor: 7.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.